Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  6, Issue 4, July-August 2019, Pages 1182-1190
 

Original Article

A Comparative Study of 0.2% Ropivacaine vs 0.25% Bupivacaine in Transverse Abdominus Plane Block for Post Operative Analgesia in Patients Undergoing Abdominal Surgery

Pradeep Kumar Das1, Hemnath Babu Kotla2

1Assistant Professor 2Associate Professor, Department of Anaesthesia, Great Eastern Medical School & Hospital, Ragolu, Srikakulam, Andhra Pradesh 532484, India.

Choose an option to locate / access this Article:
60 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6419.19

Abstract

Introduction: Several modalities have been used to alleviate pain after laparoscopic abdominal surgeries – like nonsteroidal anti-inflammatory drugs (NSAIDs), opioids (both intravenous and patient controlled analgesia, infiltration of local anaesthetic, thoracic epidural block and multimodal analgesia. Apart from providing post operative pain relief, regional anaesthetic techniques improve patient recovery by preventing the neuroendocrine responses to surgery and reducing the postoperative opioid requirements. Aim: To compare the efficacy of 0.2% ropivacaine and 0.25% bupivacaine when used in USG guided Transversus abdominus plane block for post operative analgesia in abdominal surgeries. Material and Methods: 50 patients scheduled for elective lower abdominal surgeries. The patients were randomly divided into two groups of 25 each- Group B receiving 0.25% bupivacaine, group R receiving 0.2% ropivacaine. Conducted in Department of Anesthesiology, Great Eastern Medical School & Hospital, Srikakulam. Result: Results showed no significant differences between the study groups in terms of age, weight and gender distributions. VAS showed significant difference between the study groups at 6 hrs and 12 hrs. The mean postoperative VAS in group B (0.25% bupivacaine) was maximum at the end of 6 hrs (4.08) whereas the mean postoperative VAS in group R (0.2% ropivacaine) was maximum at the end 12 hrs (4.0). Conclusions: Ropivacaine can be used as a safe alternative to Bupivacaine, routinely for TAP block for patients undergoing abdominal surgeries.


Keywords : Laparoscopic abdominal surgeries; Nonsteroidal anti-inflammatory drugs
Corresponding Author : Hemnath Babu Kotla